-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo CEO Sees 'Advantages' in Direct New York Listing

MT Newswires·09/23/2026 04:12:08
Listen to the news
04:12 AM EDT, 09/23/2026 (MT Newswires) -- Novo Nordisk (NOVO-B.CO) could consider directly listing its shares on the New York Stock Exchange, potentially replacing its American depositary receipts, London's Financial Times reported Wednesday, citing Chief Executive Officer Mike Doustdar. The Danish drugmaker is currently not pursuing such a listing, but Doustdar said he sees "some advantages" and is open to further discussions on the idea, according to the report. Doustdar added that the company is holding talks with US investors amid growing interest from investors outside Scandinavia.